Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging

Hye Jeong Lee, Mohammed N. Tantawy, KiTaek Nam, Inyeong Choi, Todd E. Peterson, Ronald R. Price

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: The objective of this study was to evaluate the syngeneic immunocompetent mouse model by using the micro-positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG microPET) imaging of ovarian tumor growth. Methods: ID8 ovarian carcinoma cells derived from C57BL/6 mice were intraperitoneally injected into female C57BL/6 mice. Mice were injected with 18F-FDG (7.4 MBq, intravenous injection), and microPET images were obtained 40 minutes later. Microcomputed tomographic images were also obtained immediately after microPET images for anatomical reference. 18F-FDG microPET images were acquired at baseline and at 4, 8, 10, and 11 weeks after tumor cell injection. The maximum standardized uptake value (SUVmax) in each time point was obtained from the images and compared to follow the tumor growth. Results: Physiological uptake of 18F-FDG was intensely found in the bladder and heart and frequently in the gastrointestinal tract. Diffused uptake of 18F-FDG was observed in the peritoneal cavity of all tumor-bearing mice at 4 weeks, and high focal uptakes were developed in the peritoneal cavity at 8 to 11 weeks. High focal uptakes increased over time, correlating with a progressive increase in the SUVmax of 18F-FDG. At 11 weeks, the SUVmax value was significantly increased (1.49 ± 0.10 at 11 weeks vs 0.29 ± 0.03 at baseline, P < 0.01). Tumors in the gut and peritoneum were confirmed by anatomical and histopathological examination. Conclusions: Our results demonstrate that the peritoneal tumor growth in the syngeneic ovarian cancer model can be detected by the 18F-FDG microPET imaging.

Original languageEnglish
Pages (from-to)22-27
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume21
Issue number1
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Fluorodeoxyglucose F18
Ovarian Neoplasms
Neoplasms
Peritoneal Cavity
Inbred C57BL Mouse
Growth
Fluorine
Peritoneum
Deoxyglucose
Intravenous Injections
Positron-Emission Tomography
Gastrointestinal Tract
Urinary Bladder
Carcinoma
Injections

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Lee, Hye Jeong ; Tantawy, Mohammed N. ; Nam, KiTaek ; Choi, Inyeong ; Peterson, Todd E. ; Price, Ronald R. / Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging. In: International Journal of Gynecological Cancer. 2011 ; Vol. 21, No. 1. pp. 22-27.
@article{06607bf4b05d4dc68418dafc58582ecb,
title = "Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging",
abstract = "Objectives: The objective of this study was to evaluate the syngeneic immunocompetent mouse model by using the micro-positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG microPET) imaging of ovarian tumor growth. Methods: ID8 ovarian carcinoma cells derived from C57BL/6 mice were intraperitoneally injected into female C57BL/6 mice. Mice were injected with 18F-FDG (7.4 MBq, intravenous injection), and microPET images were obtained 40 minutes later. Microcomputed tomographic images were also obtained immediately after microPET images for anatomical reference. 18F-FDG microPET images were acquired at baseline and at 4, 8, 10, and 11 weeks after tumor cell injection. The maximum standardized uptake value (SUVmax) in each time point was obtained from the images and compared to follow the tumor growth. Results: Physiological uptake of 18F-FDG was intensely found in the bladder and heart and frequently in the gastrointestinal tract. Diffused uptake of 18F-FDG was observed in the peritoneal cavity of all tumor-bearing mice at 4 weeks, and high focal uptakes were developed in the peritoneal cavity at 8 to 11 weeks. High focal uptakes increased over time, correlating with a progressive increase in the SUVmax of 18F-FDG. At 11 weeks, the SUVmax value was significantly increased (1.49 ± 0.10 at 11 weeks vs 0.29 ± 0.03 at baseline, P < 0.01). Tumors in the gut and peritoneum were confirmed by anatomical and histopathological examination. Conclusions: Our results demonstrate that the peritoneal tumor growth in the syngeneic ovarian cancer model can be detected by the 18F-FDG microPET imaging.",
author = "Lee, {Hye Jeong} and Tantawy, {Mohammed N.} and KiTaek Nam and Inyeong Choi and Peterson, {Todd E.} and Price, {Ronald R.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1097/IGC.0b013e3182021bda",
language = "English",
volume = "21",
pages = "22--27",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging. / Lee, Hye Jeong; Tantawy, Mohammed N.; Nam, KiTaek; Choi, Inyeong; Peterson, Todd E.; Price, Ronald R.

In: International Journal of Gynecological Cancer, Vol. 21, No. 1, 01.01.2011, p. 22-27.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging

AU - Lee, Hye Jeong

AU - Tantawy, Mohammed N.

AU - Nam, KiTaek

AU - Choi, Inyeong

AU - Peterson, Todd E.

AU - Price, Ronald R.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Objectives: The objective of this study was to evaluate the syngeneic immunocompetent mouse model by using the micro-positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG microPET) imaging of ovarian tumor growth. Methods: ID8 ovarian carcinoma cells derived from C57BL/6 mice were intraperitoneally injected into female C57BL/6 mice. Mice were injected with 18F-FDG (7.4 MBq, intravenous injection), and microPET images were obtained 40 minutes later. Microcomputed tomographic images were also obtained immediately after microPET images for anatomical reference. 18F-FDG microPET images were acquired at baseline and at 4, 8, 10, and 11 weeks after tumor cell injection. The maximum standardized uptake value (SUVmax) in each time point was obtained from the images and compared to follow the tumor growth. Results: Physiological uptake of 18F-FDG was intensely found in the bladder and heart and frequently in the gastrointestinal tract. Diffused uptake of 18F-FDG was observed in the peritoneal cavity of all tumor-bearing mice at 4 weeks, and high focal uptakes were developed in the peritoneal cavity at 8 to 11 weeks. High focal uptakes increased over time, correlating with a progressive increase in the SUVmax of 18F-FDG. At 11 weeks, the SUVmax value was significantly increased (1.49 ± 0.10 at 11 weeks vs 0.29 ± 0.03 at baseline, P < 0.01). Tumors in the gut and peritoneum were confirmed by anatomical and histopathological examination. Conclusions: Our results demonstrate that the peritoneal tumor growth in the syngeneic ovarian cancer model can be detected by the 18F-FDG microPET imaging.

AB - Objectives: The objective of this study was to evaluate the syngeneic immunocompetent mouse model by using the micro-positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG microPET) imaging of ovarian tumor growth. Methods: ID8 ovarian carcinoma cells derived from C57BL/6 mice were intraperitoneally injected into female C57BL/6 mice. Mice were injected with 18F-FDG (7.4 MBq, intravenous injection), and microPET images were obtained 40 minutes later. Microcomputed tomographic images were also obtained immediately after microPET images for anatomical reference. 18F-FDG microPET images were acquired at baseline and at 4, 8, 10, and 11 weeks after tumor cell injection. The maximum standardized uptake value (SUVmax) in each time point was obtained from the images and compared to follow the tumor growth. Results: Physiological uptake of 18F-FDG was intensely found in the bladder and heart and frequently in the gastrointestinal tract. Diffused uptake of 18F-FDG was observed in the peritoneal cavity of all tumor-bearing mice at 4 weeks, and high focal uptakes were developed in the peritoneal cavity at 8 to 11 weeks. High focal uptakes increased over time, correlating with a progressive increase in the SUVmax of 18F-FDG. At 11 weeks, the SUVmax value was significantly increased (1.49 ± 0.10 at 11 weeks vs 0.29 ± 0.03 at baseline, P < 0.01). Tumors in the gut and peritoneum were confirmed by anatomical and histopathological examination. Conclusions: Our results demonstrate that the peritoneal tumor growth in the syngeneic ovarian cancer model can be detected by the 18F-FDG microPET imaging.

UR - http://www.scopus.com/inward/record.url?scp=79951480729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951480729&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e3182021bda

DO - 10.1097/IGC.0b013e3182021bda

M3 - Article

VL - 21

SP - 22

EP - 27

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 1

ER -